The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis
Medium-chain fatty acids (MCFAs) have been associated with anti-steatotic effects in hepatocytes. Expression of the MCFA receptor GPR84 (G protein-coupled receptor 84) is induced in immune cells under inflammatory conditions and can promote fibrogenesis. We aimed at deciphering the role of GPR84 in...
Gespeichert in:
| Veröffentlicht in: | Journal of clinical medicine 2020-04, Vol.9 (4), p.1140 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 4 |
| container_start_page | 1140 |
| container_title | Journal of clinical medicine |
| container_volume | 9 |
| creator | Puengel, Tobias De Vos, Steve Hundertmark, Jana Kohlhepp, Marlene Guldiken, Nurdan Pujuguet, Philippe Auberval, Marielle Marsais, Florence Shoji, Kenji F Saniere, Laurent Trautwein, Christian Luedde, Tom Strnad, Pavel Brys, Reginald Clément-Lacroix, Philippe Tacke, Frank |
| description | Medium-chain fatty acids (MCFAs) have been associated with anti-steatotic effects in hepatocytes. Expression of the MCFA receptor GPR84 (G protein-coupled receptor 84) is induced in immune cells under inflammatory conditions and can promote fibrogenesis. We aimed at deciphering the role of GPR84 in the pathogenesis of non-alcoholic steatohepatitis (NASH), exploring its potential as a therapeutic target. GPR84 expression is upregulated in liver from patients with non-alcoholic fatty liver disease (NAFLD), correlating with the histological degree of inflammation and fibrosis. In mouse and human, activated monocytes and neutrophils upregulate GPR84 expression. Chemotaxis of these myeloid cells by GPR84 stimulation is inhibited by two novel, small molecule GPR84 antagonists. Upon acute liver injury in mice, treatment with GPR84 antagonists significantly reduced the hepatic recruitment of neutrophils, monocytes, and monocyte-derived macrophages (MoMF). We, therefore, evaluated the therapeutic inhibition of GPR84 by these two novel antagonists in comparison to selonsertib, an apoptosis signal-regulating kinase 1 (ASK1) inhibitor, in three NASH mouse models. Pharmacological inhibition of GPR84 significantly reduced macrophage accumulation and ameliorated inflammation and fibrosis, to an extent similar to selonsertib. In conclusion, our findings support that GPR84 mediates myeloid cell infiltration in liver injury and is a promising therapeutic target in steatohepatitis and fibrosis. |
| doi_str_mv | 10.3390/jcm9041140 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7231190</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2641058955</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-cbc4e47ce93269ee0f720dbdf06917a9672b60795abe3ab57bebb5a3bf1f28693</originalsourceid><addsrcrecordid>eNpdkd1rFDEUxYMottS--AdIwBcRpuZrJpMXoSxuLbRYan0OSeZON8tMsiYZYf97Y7-s5uUGzo_Dufcg9JaSE84V-bR1syKCUkFeoENGpGwI7_nLZ_8DdJzzltTX94JR-RodcMZpx3h7iMrNBvAlDH6Zm9XG-IDXppQ9PnV-wNfgYFdiwmdX1724w0yBjC_3MMWqr2Ca8HkY_VSSKT4GfJXiHIsPt_h7AVPiBnZVKD5jEwa89jbF7PMb9Go0U4bjh3mEfqy_3Ky-Nhffzs5XpxeNE5KVxlknQEgHirNOAZBRMjLYYSSdotKoTjLbEalaY4Eb20oL1raG25GOrO8UP0Kf7313i51hcBBqzknvkp9N2utovP5XCX6jb-MvLet9qCLV4MODQYo_F8hFzz67urUJEJesGVe8lVy0bUXf_4du45JCXU-zTlDS9uqO-nhPuXqInGB8CkOJ_tOn_ttnhd89j_-EPrbHfwNL0JxK</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2641058955</pqid></control><display><type>article</type><title>The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis</title><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Puengel, Tobias ; De Vos, Steve ; Hundertmark, Jana ; Kohlhepp, Marlene ; Guldiken, Nurdan ; Pujuguet, Philippe ; Auberval, Marielle ; Marsais, Florence ; Shoji, Kenji F ; Saniere, Laurent ; Trautwein, Christian ; Luedde, Tom ; Strnad, Pavel ; Brys, Reginald ; Clément-Lacroix, Philippe ; Tacke, Frank</creator><creatorcontrib>Puengel, Tobias ; De Vos, Steve ; Hundertmark, Jana ; Kohlhepp, Marlene ; Guldiken, Nurdan ; Pujuguet, Philippe ; Auberval, Marielle ; Marsais, Florence ; Shoji, Kenji F ; Saniere, Laurent ; Trautwein, Christian ; Luedde, Tom ; Strnad, Pavel ; Brys, Reginald ; Clément-Lacroix, Philippe ; Tacke, Frank</creatorcontrib><description>Medium-chain fatty acids (MCFAs) have been associated with anti-steatotic effects in hepatocytes. Expression of the MCFA receptor GPR84 (G protein-coupled receptor 84) is induced in immune cells under inflammatory conditions and can promote fibrogenesis. We aimed at deciphering the role of GPR84 in the pathogenesis of non-alcoholic steatohepatitis (NASH), exploring its potential as a therapeutic target. GPR84 expression is upregulated in liver from patients with non-alcoholic fatty liver disease (NAFLD), correlating with the histological degree of inflammation and fibrosis. In mouse and human, activated monocytes and neutrophils upregulate GPR84 expression. Chemotaxis of these myeloid cells by GPR84 stimulation is inhibited by two novel, small molecule GPR84 antagonists. Upon acute liver injury in mice, treatment with GPR84 antagonists significantly reduced the hepatic recruitment of neutrophils, monocytes, and monocyte-derived macrophages (MoMF). We, therefore, evaluated the therapeutic inhibition of GPR84 by these two novel antagonists in comparison to selonsertib, an apoptosis signal-regulating kinase 1 (ASK1) inhibitor, in three NASH mouse models. Pharmacological inhibition of GPR84 significantly reduced macrophage accumulation and ameliorated inflammation and fibrosis, to an extent similar to selonsertib. In conclusion, our findings support that GPR84 mediates myeloid cell infiltration in liver injury and is a promising therapeutic target in steatohepatitis and fibrosis.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm9041140</identifier><identifier>PMID: 32316235</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Animals ; Apoptosis ; Carbohydrates ; Clinical medicine ; Diet ; Experiments ; Fatty acids ; Gene expression ; Kinases ; Lipids ; Liver diseases ; Metabolism ; Metabolites ; Neutrophils ; Pathogens</subject><ispartof>Journal of clinical medicine, 2020-04, Vol.9 (4), p.1140</ispartof><rights>2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-cbc4e47ce93269ee0f720dbdf06917a9672b60795abe3ab57bebb5a3bf1f28693</citedby><cites>FETCH-LOGICAL-c472t-cbc4e47ce93269ee0f720dbdf06917a9672b60795abe3ab57bebb5a3bf1f28693</cites><orcidid>0000-0002-7122-6379 ; 0000-0003-2662-6127</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231190/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231190/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32316235$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Puengel, Tobias</creatorcontrib><creatorcontrib>De Vos, Steve</creatorcontrib><creatorcontrib>Hundertmark, Jana</creatorcontrib><creatorcontrib>Kohlhepp, Marlene</creatorcontrib><creatorcontrib>Guldiken, Nurdan</creatorcontrib><creatorcontrib>Pujuguet, Philippe</creatorcontrib><creatorcontrib>Auberval, Marielle</creatorcontrib><creatorcontrib>Marsais, Florence</creatorcontrib><creatorcontrib>Shoji, Kenji F</creatorcontrib><creatorcontrib>Saniere, Laurent</creatorcontrib><creatorcontrib>Trautwein, Christian</creatorcontrib><creatorcontrib>Luedde, Tom</creatorcontrib><creatorcontrib>Strnad, Pavel</creatorcontrib><creatorcontrib>Brys, Reginald</creatorcontrib><creatorcontrib>Clément-Lacroix, Philippe</creatorcontrib><creatorcontrib>Tacke, Frank</creatorcontrib><title>The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis</title><title>Journal of clinical medicine</title><addtitle>J Clin Med</addtitle><description>Medium-chain fatty acids (MCFAs) have been associated with anti-steatotic effects in hepatocytes. Expression of the MCFA receptor GPR84 (G protein-coupled receptor 84) is induced in immune cells under inflammatory conditions and can promote fibrogenesis. We aimed at deciphering the role of GPR84 in the pathogenesis of non-alcoholic steatohepatitis (NASH), exploring its potential as a therapeutic target. GPR84 expression is upregulated in liver from patients with non-alcoholic fatty liver disease (NAFLD), correlating with the histological degree of inflammation and fibrosis. In mouse and human, activated monocytes and neutrophils upregulate GPR84 expression. Chemotaxis of these myeloid cells by GPR84 stimulation is inhibited by two novel, small molecule GPR84 antagonists. Upon acute liver injury in mice, treatment with GPR84 antagonists significantly reduced the hepatic recruitment of neutrophils, monocytes, and monocyte-derived macrophages (MoMF). We, therefore, evaluated the therapeutic inhibition of GPR84 by these two novel antagonists in comparison to selonsertib, an apoptosis signal-regulating kinase 1 (ASK1) inhibitor, in three NASH mouse models. Pharmacological inhibition of GPR84 significantly reduced macrophage accumulation and ameliorated inflammation and fibrosis, to an extent similar to selonsertib. In conclusion, our findings support that GPR84 mediates myeloid cell infiltration in liver injury and is a promising therapeutic target in steatohepatitis and fibrosis.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Carbohydrates</subject><subject>Clinical medicine</subject><subject>Diet</subject><subject>Experiments</subject><subject>Fatty acids</subject><subject>Gene expression</subject><subject>Kinases</subject><subject>Lipids</subject><subject>Liver diseases</subject><subject>Metabolism</subject><subject>Metabolites</subject><subject>Neutrophils</subject><subject>Pathogens</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkd1rFDEUxYMottS--AdIwBcRpuZrJpMXoSxuLbRYan0OSeZON8tMsiYZYf97Y7-s5uUGzo_Dufcg9JaSE84V-bR1syKCUkFeoENGpGwI7_nLZ_8DdJzzltTX94JR-RodcMZpx3h7iMrNBvAlDH6Zm9XG-IDXppQ9PnV-wNfgYFdiwmdX1724w0yBjC_3MMWqr2Ca8HkY_VSSKT4GfJXiHIsPt_h7AVPiBnZVKD5jEwa89jbF7PMb9Go0U4bjh3mEfqy_3Ky-Nhffzs5XpxeNE5KVxlknQEgHirNOAZBRMjLYYSSdotKoTjLbEalaY4Eb20oL1raG25GOrO8UP0Kf7313i51hcBBqzknvkp9N2utovP5XCX6jb-MvLet9qCLV4MODQYo_F8hFzz67urUJEJesGVe8lVy0bUXf_4du45JCXU-zTlDS9uqO-nhPuXqInGB8CkOJ_tOn_ttnhd89j_-EPrbHfwNL0JxK</recordid><startdate>20200416</startdate><enddate>20200416</enddate><creator>Puengel, Tobias</creator><creator>De Vos, Steve</creator><creator>Hundertmark, Jana</creator><creator>Kohlhepp, Marlene</creator><creator>Guldiken, Nurdan</creator><creator>Pujuguet, Philippe</creator><creator>Auberval, Marielle</creator><creator>Marsais, Florence</creator><creator>Shoji, Kenji F</creator><creator>Saniere, Laurent</creator><creator>Trautwein, Christian</creator><creator>Luedde, Tom</creator><creator>Strnad, Pavel</creator><creator>Brys, Reginald</creator><creator>Clément-Lacroix, Philippe</creator><creator>Tacke, Frank</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7122-6379</orcidid><orcidid>https://orcid.org/0000-0003-2662-6127</orcidid></search><sort><creationdate>20200416</creationdate><title>The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis</title><author>Puengel, Tobias ; De Vos, Steve ; Hundertmark, Jana ; Kohlhepp, Marlene ; Guldiken, Nurdan ; Pujuguet, Philippe ; Auberval, Marielle ; Marsais, Florence ; Shoji, Kenji F ; Saniere, Laurent ; Trautwein, Christian ; Luedde, Tom ; Strnad, Pavel ; Brys, Reginald ; Clément-Lacroix, Philippe ; Tacke, Frank</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-cbc4e47ce93269ee0f720dbdf06917a9672b60795abe3ab57bebb5a3bf1f28693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Carbohydrates</topic><topic>Clinical medicine</topic><topic>Diet</topic><topic>Experiments</topic><topic>Fatty acids</topic><topic>Gene expression</topic><topic>Kinases</topic><topic>Lipids</topic><topic>Liver diseases</topic><topic>Metabolism</topic><topic>Metabolites</topic><topic>Neutrophils</topic><topic>Pathogens</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Puengel, Tobias</creatorcontrib><creatorcontrib>De Vos, Steve</creatorcontrib><creatorcontrib>Hundertmark, Jana</creatorcontrib><creatorcontrib>Kohlhepp, Marlene</creatorcontrib><creatorcontrib>Guldiken, Nurdan</creatorcontrib><creatorcontrib>Pujuguet, Philippe</creatorcontrib><creatorcontrib>Auberval, Marielle</creatorcontrib><creatorcontrib>Marsais, Florence</creatorcontrib><creatorcontrib>Shoji, Kenji F</creatorcontrib><creatorcontrib>Saniere, Laurent</creatorcontrib><creatorcontrib>Trautwein, Christian</creatorcontrib><creatorcontrib>Luedde, Tom</creatorcontrib><creatorcontrib>Strnad, Pavel</creatorcontrib><creatorcontrib>Brys, Reginald</creatorcontrib><creatorcontrib>Clément-Lacroix, Philippe</creatorcontrib><creatorcontrib>Tacke, Frank</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Puengel, Tobias</au><au>De Vos, Steve</au><au>Hundertmark, Jana</au><au>Kohlhepp, Marlene</au><au>Guldiken, Nurdan</au><au>Pujuguet, Philippe</au><au>Auberval, Marielle</au><au>Marsais, Florence</au><au>Shoji, Kenji F</au><au>Saniere, Laurent</au><au>Trautwein, Christian</au><au>Luedde, Tom</au><au>Strnad, Pavel</au><au>Brys, Reginald</au><au>Clément-Lacroix, Philippe</au><au>Tacke, Frank</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis</atitle><jtitle>Journal of clinical medicine</jtitle><addtitle>J Clin Med</addtitle><date>2020-04-16</date><risdate>2020</risdate><volume>9</volume><issue>4</issue><spage>1140</spage><pages>1140-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>Medium-chain fatty acids (MCFAs) have been associated with anti-steatotic effects in hepatocytes. Expression of the MCFA receptor GPR84 (G protein-coupled receptor 84) is induced in immune cells under inflammatory conditions and can promote fibrogenesis. We aimed at deciphering the role of GPR84 in the pathogenesis of non-alcoholic steatohepatitis (NASH), exploring its potential as a therapeutic target. GPR84 expression is upregulated in liver from patients with non-alcoholic fatty liver disease (NAFLD), correlating with the histological degree of inflammation and fibrosis. In mouse and human, activated monocytes and neutrophils upregulate GPR84 expression. Chemotaxis of these myeloid cells by GPR84 stimulation is inhibited by two novel, small molecule GPR84 antagonists. Upon acute liver injury in mice, treatment with GPR84 antagonists significantly reduced the hepatic recruitment of neutrophils, monocytes, and monocyte-derived macrophages (MoMF). We, therefore, evaluated the therapeutic inhibition of GPR84 by these two novel antagonists in comparison to selonsertib, an apoptosis signal-regulating kinase 1 (ASK1) inhibitor, in three NASH mouse models. Pharmacological inhibition of GPR84 significantly reduced macrophage accumulation and ameliorated inflammation and fibrosis, to an extent similar to selonsertib. In conclusion, our findings support that GPR84 mediates myeloid cell infiltration in liver injury and is a promising therapeutic target in steatohepatitis and fibrosis.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>32316235</pmid><doi>10.3390/jcm9041140</doi><orcidid>https://orcid.org/0000-0002-7122-6379</orcidid><orcidid>https://orcid.org/0000-0003-2662-6127</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2077-0383 |
| ispartof | Journal of clinical medicine, 2020-04, Vol.9 (4), p.1140 |
| issn | 2077-0383 2077-0383 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7231190 |
| source | PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Animals Apoptosis Carbohydrates Clinical medicine Diet Experiments Fatty acids Gene expression Kinases Lipids Liver diseases Metabolism Metabolites Neutrophils Pathogens |
| title | The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T12%3A46%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Medium-Chain%20Fatty%20Acid%20Receptor%20GPR84%20Mediates%20Myeloid%20Cell%20Infiltration%20Promoting%20Steatohepatitis%20and%20Fibrosis&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Puengel,%20Tobias&rft.date=2020-04-16&rft.volume=9&rft.issue=4&rft.spage=1140&rft.pages=1140-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm9041140&rft_dat=%3Cproquest_pubme%3E2641058955%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2641058955&rft_id=info:pmid/32316235&rfr_iscdi=true |